🧬 WHAT WE'RE BUILDING
🚀 Revolutionary All-in-One Health Platform: AICENNA Digital Twin integrates real-time biosensing, AI analytics, genomics, and digital twin simulations to deliver proactive, personalized, and predictive healthcare—moving beyond traditional, reactive models.
🤖 Advanced Technology Integration: Combines wearables, Health IoT, DNA methylation analysis, conversational AI, and a clinician-facing MedAI Studio to enable early disease detection, dynamic treatment planning, and continuous patient monitoring.
📈 WHY IT MATTERS
🌍 Strong Market Positioning: Targets a rapidly growing global digital health market (USD 946B by 2030) and a booming digital twin sector (25.9% CAGR), with solutions tailored for hospitals, insurers, researchers, and consumers.
💸 Diverse Revenue Streams: Monetized through multi-tier SaaS and subscription models, licensing, outcome-based pricing, and customizable AI model development tools for clinicians.
📊 Robust Financials and High ROI: With a setup cost of USD 10M, the project offers a payback period of under 3 years, driven by scalable infrastructure, improving margins, and high-value Tier 3 client services.
⚙️ BUILT FOR SCALE
🔗 Scalable and Regulation-Ready: Built with modular, API-friendly architecture allowing for fast expansion, vendor onboarding, and integration into regulatory-compliant healthcare systems.
🧑⚕️ Clinician-Driven Innovation: MedAI Studio enables healthcare professionals to build, test, and deploy AI models in real time—fostering continuous improvement and personalization in patient care.
💡 AICENNA Digital Twin is redefining the future of healthcare—smarter, faster, and more personal.
🔮 Pitch Deck
